In vivo pathology: Seeing with molecular specificity and cellular resolution in the living body

Annual Review of Pathology

Volumn 2, Issue , 2007, Pages 277-305

  Contag, Christopher H ^a  

^a STANFORD UNIVERSITY   (United States)

Author keywords

Biophotonics; Cancer therapy; Hematopoiesis; Hematopoietic stem cells; Luciferase; Regenerative medicine; Stem cells

Indexed keywords

FLUORODEOXYGLUCOSE; LUCIFERASE; TRACER;

BREAST CANCER; CANCER THERAPY; FLUORESCENCE; GENE TRANSFER; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HUMAN; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; INTERMETHOD COMPARISON; ISOTOPE LABELING; MOLECULAR DYNAMICS; MOLECULAR IMAGING; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTICAL COHERENCE TOMOGRAPHY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIOCHEMISTRY; RADIOFREQUENCY; REGENERATIVE MEDICINE; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STEM CELL TRANSPLANTATION; TECHNOLOGY; ULTRASOUND;

EID: 33947362062     PISSN: 15534006     EISSN: 15534014     Source Type: Book Series    
DOI: 10.1146/annurev.pathol.2.010506.091930     Document Type: Review

References (173)

1. Crawford JM, Tykocinski ML. 2005. Pathology as the enabler of human research. Lab. Invest. 85:1058-64
2. Contag PR, Olomu IN, Stevenson DK, Contag CH. 1998. Bioluminescent indicators in living mammals. Nat. Med. 4:245-47
3. Contag CH, Spilman SD, Contag PR, Oshiro M, Eames B, et al. 1997. Visualizing gene expression in living mammals using a bioluminescent reporter. Photochem. Photobiol. 66:523-31
4. Contag CH, Contag PR, Mullins JI, Spilman SD, Stevenson DK, Benaron DA. 1995. Photonic detection of bacterial pathogens in living hosts. Mol. Microbiol. 18:593-603
5. Gambhir SS, Herschman HR, Cherry SR, Barrio JR, Satyamurthy N, et al. 2000. Imaging transgene expression with radionuclide imaging technologies. Neoplasia 2:118-38
6. Chalfie M. 1995. Green fluorescent protein. Photochem. Photobiol. 62:651-56
7. Chalfie M, Tu Y, Euskirchen G, Ward WW, Prasher DC. 1994. Green fluorescent protein as a marker for gene expression. Science 263:802-5
8. Tolar J, Osborn M, Bell S, McElmurry R, Xia L, et al. 2005. Real-time in vivo imaging of stem cells following transgenesis by transposition. Mol. Ther. 12:42-48
9. Zhang M, Alicot EM, Chiu I, Li J, Verna N, et al. 2006. Identification of the target self-antigens in reperfusion injury. J. Exp. Med. 203:141-52
10. Siegel RM, Chan FK, Zacharias DA, Swofford R, Holmes KL, et al. 2000. Measurement of molecular interactions in living cells by fluorescence resonance energy transfer between variants of the green fluorescent protein. Sci. STKE 2000:PL1
11. Tsien RY. 1998. The green fluorescent protein. Annu. Rev. Biochem. 67:509-44
12. Tsien RY, Miyawaki A. 1998. Seeing the machinery of live cells. Science 280:1954-55
13. Cubitt AB, Heim R, Adams SR, Boyd AE, Gross LA, Tsien RY. 1995. Understanding, improving and using green fluorescent proteins. Trends Biochem. Sci. 20:448-55
14. Louie AY, Huber MM, Ahrens ET, Rothbacher U, Moats R, et al. 2000. In vivo visualization of gene expression using magnetic resonance imaging. Nat. Biotechnol. 18:321-25
15. Moore A, Basilion JP, Chiocca EA, Weissleder R. 1998. Measuring transferrin receptor gene expression by NMR imaging. Biochim. Biophys. Acta 1402:239-49
16. Funovics M, Weissleder R, Tung CH. 2003. Protease sensors for bioimaging. Anal. Bioanal. Chem. 377:956-63
17. Jaffer FA, Tung CH, Gerszten RE, Weissleder R. 2002. In vivo imaging of thrombin activity in experimental thrombi with thrombin-sensitive near-infrared molecular probe. Arterioscler. Thromb. Vasc. Biol. 22:1929-35
18. Chen J, Tung CH, Mahmood U, Ntziachristos V, Gyurko R, et al. 2002. In vivo imaging of proteolytic activity in atherosclerosis. Circulation 105:2766-71
19. Weissleder R, Tung CH, Mahmood U, Bogdanov AJ. 1999. In vivo imaging of tumors with protease-activated near-infrared fluorescent probes. Nat. Biotechnol. 17:375-78
20. Ericson K, Bergstrom M, Eriksson L. 1980. Positron emission tomography in the evaluation of subdural hematomas. J. Comput. Assist. Tomogr. 4:737-45
21. Geltman EM, Roberts R, Sobel BE. 1980. Cardiac positron tomography: current status and future directions. Herz 5:107-19
22. Hoffman EJ, van der Stee M, Ricci AR, Phelps ME. 1984. Prospects for both precision and accuracy in positron emission tomography. Ann. Neurol. 15(Suppl.):S25-34
23. Phelps ME, Mazziotta JC, Baxter L, Gerner R. 1984. Positron emission tomographic study of affective disorders: problems and strategies. Ann. Neurol. 15(Suppl.):S149-56
24. Wagner HNJ. 1986. Quantitative imaging of neuroreceptors in the living human brain. Semin. Nucl. Med. 16:51-62
25. Bice AN, Links JM, Wong DF, Wagner HNJ. 1985. Absorbed fractions for dose calculations of neuroreceptor PET studies. Eur. J. Nucl. Med. 11:127-31
26. Jaffer FA, Weissleder R. 2005. Molecular imaging in the clinical arena. JAMA 293:855-62
27. Kelloff GJ, Krohn KA, Larson SM, Weissleder R, Mankoff DA, et al. 2005. The progress and promise of molecular imaging probes in oncologic drug development. Clin. Cancer Res. 11:7967-85
28. Ntziachristos V, Ripoll J, Wang LV, Weissleder R. 2005. Looking and listening to light: the evolution of whole-body photonic imaging. Nat. Biotechnol. 23:313-20
29. Contag CH, Bachmann MH. 2002. Advances in in vivo bioluminescence imaging of gene expression. Annu. Rev. Biomed. Eng. 4:235-60
30. Contag CH, Ross BD. 2002. It's not just about anatomy: in vivo bioluminescence imaging as an eyepiece into biology. J. Magn. Reson. Imaging 16:378-87
31. O'Connell-Rodwell CE, Burns SM, Bachmann MH, Contag CH. 2002. Bioluminescent indicators for in vivo measurements of gene expression. Trends Biotechnol. 20:S19-23
32. Weissleder R. 2006. Molecular imaging in cancer. Science 312:1168-71
33. Nielsen TO, West RB, Linn SC, Alter O, Knowling MA, et al. 2002. Molecular characterisation of soft tissue tumours: a gene expression study. Lancet 359:1301-7
34. Krogsgaard M, Huppa JB, Purbhoo MA, Davis MM. 2003. Linking molecular and cellular events in T-cell activation and synapse formation. Semin. Immunol. 15:307-15
35. Davis MM, Krogsgaard M, Huppa JB, Sumen C, Purbhoo MA, et al. 2003. Dynamics of cell surface molecules during T cell recognition. Annu. Rev. Biochem. 72:717-42
36. Huppa JB, Gleimer M, Sumen C, Davis MM. 2003. Continuous T cell receptor signaling required for synapse maintenance and full effector potential. Nat. Immunol. 4:749-55
37. Stephens DJ, Allan VJ. 2003. Light microscopy techniques for live cell imaging. Science 300:82-86
38. Gambhir SS, Barrio JR, Wu L, Iyer M, Namavari M, et al. 1998. Imaging of adenoviral-directed herpes simplex virus type 1 thymidine kinase reporter gene expression in mice with radiolabeled ganciclovir. J. Nucl. Med. 39:2003-11
39. Incesu L, Yazicioglu AK, Selcuk MB, Ozen N. 2004. Contrast-enhanced power Doppler US in the diagnosis of acute appendicitis. Eur. J. Radiol. 50:201-9
40. Bull SR, Guler MO, Bras RE, Venkatasubramanian PN, Stupp SI, Meade TJ. 2005. Magnetic resonance imaging of self-assembled biomaterial scaffolds. Bioconjug. Chem. 16:1343-48
41. Meade T. 2001. Seeing is believing. Acad. Radiol. 8:1-3
42. Weber SM, Peterson KA, Durkee B, Qi C, Longino M, et al. 2004. Imaging of murine liver tumor using microct with a hepatocyte-selective contrast agent: accuracy is dependent on adequate contrast enhancement. J. Surg. Res. 119:41-45
43. May DJ, Allen JS, Ferrara KW. 2002. Dynamics and fragmentation of thick-shelled microbubbles. IEEE Trans. Ultrason. Ferroelectr. Frequation Control 49:1400-10
44. Stride E, Saffari N. 2003. Microbubble ultrasound contrast agents: a review. Proc. Inst. Mech. Eng. [H] 217:429-47
45. Chomas JE, Dayton P, Allen J, Morgan K, Ferrara KW. 2001. Mechanisms of contrast agent destruction. IEEE Trans. Ultrason. Ferroelectr. Frequation Control 48:232-48
46. Tjuvajev JG, Stockhammer G, Desai R, Uehara H, Watanabe K, et al. 1995. Imaging the expression of transfected genes in vivo. Cancer Res. 55:6126-32
47. Tjuvajev JG, Finn R, Watanabe K, Joshi R, Oku T, et al. 1996. Noninvasive imaging of herpes virus thymidine kinase gene transfer and expression: a potential method for monitoring clinical gene therapy. Cancer Res. 56:4087-95
48. Tjuvajev JG, Avril N, Oku T, Sasajima T, Miyagawa T, et al. 1998. Imaging herpes virus thymidine kinase gene transfer and expression by positron emission tomography. Cancer Res. 58:4333-41
49. Gambhir SS, Barrio JR, Herschman HR, Phelps ME. 1999. Assays for noninvasive imaging of reporter gene expression. Nucl. Med. Biol. 26:481-90
50. Stodilka RZ, Blackwood KJ, Prato FS. 2006. Tracking transplanted cells using dual-radionuclide SPECT. Phys. Med. Biol. 51:2619-32
51. Acton PD, Zhou R. 2005. Imaging reporter genes for cell tracking with PET and SPECT. Q.J. Nucl. Med. Mol. Imaging 49:349-60
52. Che J, Doubrovin M, Serganova I, Ageyeva L, Zanzonico P, Blasberg R. 2005. hNIS-IRES-eGFP dual reporter gene imaging. Mol. Imaging 4:128-36
53. Bennink RJ, van Montfrans C, de Jonge WJ, de Bruin K, van Deventer SJ, te Velde AA. 2004. Imaging of intestinal lymphocyte homing by means of pinhole SPECT in a TNBS colitis mouse model. Nucl. Med. Biol. 31:93-101
54. Chin BB, Nakamoto Y, Bulte JW, Pittenger MF, Wahl R, Kraitchman DL. 2003. 111In oxine labelled mesenchymal stem cell SPECT after intravenous administration in myocardial infarction. Nucl. Med. Commun. 24:1149-54
55. Cui J, Wahl RL, Shen T, Fisher SJ, Recker E, et al. 1999. Bone marrow cell trafficking following intravenous administration. Br. J. Haematol. 107:895-902
56. Adonai N, Nguyen KN, Walsh J, Iyer M, Toyokuni T, et al. 2002. Ex vivo cell labeling with 64Cu-pyruvaldehyde-bis(N4-methylthiosemicarbazone) for imaging cell trafficking in mice with positron-emission tomography. Proc. Natl. Acad. Sci. USA 99:3030-35
57. Rice BW, Cable MD, Nelson MB. 2001. In vivo imaging of light-emitting probes. J. Biomed. Opt. 6:432-40
58. Tromberg BJ, Shah N, Lanning R, Cerussi A, Espinoza J, et al. 2000. Non-invasive in vivo characterization of breast tumors using photon migration spectroscopy. Neoplasia 2:26-40
59. Tromberg BJ, Cerussi A, Shah N, Compton M, Durkin A, et al. 2005. Imaging in breast cancer: diffuse optics in breast cancer: detecting tumors in pre-menopausal women and monitoring neoadjuvant chemotherapy. Breast Cancer Res. 7:279-85
60. Chwirot BW, Kowalska M, Plociennik N, Piwinski M, Michniewicz Z, Chwirot S. 2003. Variability of spectra of laser-induced fluorescence of colonic mucosa: its significance for fluorescence detection of colonic neoplasia. Indian J. Exp. Biol. 41:500-10
61. DaCosta RS, Andersson H, Cirocco M, Marcon NE, Wilson BC. 2005. Autofluorescence characterisation of isolated whole crypts and primary cultured human epithelial cells from normal, hyperplastic, and adenomatous colonic mucosa. J. Clin. Pathol. 58:766-74
62. DaCosta RS, Wilson BC, Marcon NE. 2005. Optical techniques for the endoscopic detection of dysplastic colonic lesions. Curr. Opin. Gastroenterol. 21:70-79
63. Haringsma J, Tytgat GN, Yano H, Iishi H, Tatsuta M, et al. 2001. Autofluorescence endoscopy: feasibility of detection of GI neoplasms unapparent to white light endoscopy with an evolving technology. Gastrointest. Endosc. 53:642-50
64. Lin Y, Weissleder R, Tung CH. 2002. Novel near-infrared cyanine fluorochromes: synthesis, properties, and bioconjugation. Bioconjug. Chem. 13:605-10
65. Wang CY, Lin JK, Chen BF, Chiang HK. 1999. Autofluorescence spectroscopic differentiation between normal and cancerous colorectal tissues by means of a two-peak ratio algorithm. J. Formos. Med. Assoc. 98:837-43
66. Fujimoto JG. 2003. Optical coherence tomography for ultrahigh resolution in vivo imaging. Nat. Biotechnol. 21:1361-67
67. Fujimoto JG, Pitris C, Boppart SA, Brezinski ME. 2000. Optical coherence tomography: an emerging technology for biomedical imaging and optical biopsy. Neoplasia 2:9-25
68. Sweeney TJ, Mailander V, Tucker AA, Olomu AB, Zhang W, et al. 1999. Visualizing the kinetics of tumor-cell clearance in living animals. Proc. Natl. Acad. Sci. USA 96:12044-49
69. Thorne SH, Negrin RS, Contag CH. 2006. Synergistic antitumor effects of immune cell-viral biotherapy. Science 311:1780-84
70. Bloch S, Lesage F, McIntosh L, Gandjbakhche A, Liang K, Achilefu S. 2005. Whole-body fluorescence lifetime imaging of a tumor-targeted near-infrared molecular probe in mice. J. Biomed. Opt. 10:54003-11
71. Chaudhari AJ, Darvas F, Bading JR, Moats RA, Conti PS, et al. 2005. Hyperspectral and multispectral bioluminescence optical tomography for small animal imaging. Phys. Med. Biol. 50:5421-41
72. Ntziachristos V, Bremer C, Weissleder R. 2003. Fluorescence imaging with near-infrared light: new technological advances that enable in vivo molecular imaging. Eur. Radiol. 13:195-208
73. Tonary AM, Pezacki JP. 2006. Simultaneous quantitative measurement of luciferase reporter activity and cell number in two- and three-dimensional cultures of hepatitis C virus replicons. Anal. Biochem. 350:239-48
74. Kadurugamuwa JL, Modi K, Coquoz O, Rice B, Smith S, et al. 2005. Reduction of astrogliosis by early treatment of pneumococcal meningitis measured by simultaneous imaging, in vivo, of the pathogen and host response. Infect. Immun. 73:7836-43
75. Hoffman RM. 2005. Advantages of multi-color fluorescent proteins for whole-body and in vivo cellular imaging. J. Biomed. Opt. 10:41202
76. Wood KV. 1990. Luc genes: introduction of colour into bioluminescence assays. J. Bio lumin. Chemilumin. 5:107-14
77. Wood KV, Lam YA, Seliger HH, McElroy WD. 1989. Complementary DNA coding click beetle luciferases can elicit bioluminescence of different colors. Science 244:700-2
78. Hastings JW. 1996. Chemistries and colors of bioluminescent reactions: a review. Gene 173:5-11
79. McCaffrey A, Kay MA, Contag CH. 2003. Advancing molecular therapies through in vivo bioluminescent imaging. Mol. Imaging 2:75-86
80. Doyle TC, Burns SM, Contag CH. 2004. In vivo bioluminescence imaging for integrated studies of infection. Cell Microbiol. 6:303-17
81. Sadikot RT, Blackwell TS. 2005. Bioluminescence imaging. Proc. Am. Thorac. Soc. 2:537-40
82. Troy T, Jekic-McMullen D, Sambucetti L, Rice B. 2004. Quantitative comparison of the sensitivity of detection of fluorescent and bioluminescent reporters in animal models. Mol. Imaging 3:9-23
83. Steele RW. 1991. Clinical applications of chemiluminescence of granulocytes. Rev. Infect. Dis. 13:918-25
84. Stolz U, Velez S, Wood KV, Wood M, Feder JL. 2003. Darwinian natural selection for orange bioluminescent color in a Jamaican click beetle. Proc. Natl. Acad. Sci. USA 100:14955-59
85. Zhao H, Doyle TC, Coquoz O, Kalish F, Rice B W, Contag CH. 2005. Emission spectra of bioluminescent reporters and interaction with mammalian tissue determine the sensitivity of detection in vivo. J. Biomed. Opt. 10:41210
86. Ntziachristos V, Tung CH, Bremer C, Weissleder R. 2002. Fluorescence molecular tomography resolves protease activity in vivo. Nat. Med. 8:757-60
87. Tung CH, Zeng Q, Shah K, Kim DE, Schellingerhout D, Weissleder R. 2004. In vivo imaging of β-galactosidase activity using far red fluorescent switch. Cancer Res. 64:1579-83
88. Kircher MF, Weissleder R, Josephson L. 2004. A dual fluorochrome probe for imaging proteases. Bioconjug. Chem. 15:242-48
89. Yang M, Baranov E, Jiang P, Sun EX, Li XM, et al. 2000. Whole-body optical imaging of green fluorescent protein-expressing tumors and metastases. Proc. Natl. Acad. Sci. USA 97:1206-11
90. Hoffman R. 2002. Green fluorescent protein imaging of tumour growth, metastasis, and angiogenesis in mouse models. Lancet. Oncol. 3:546-56
91. Kumar AT, Skoch J, Bacskai BJ, Boas DA, Dunn AK. 2005. Fluorescence-lifetime-based tomography for turbid media. Opt. Lett. 30:3347-49
92. Merk S, Lietz A, Kroner M, Valler M, Heilker R. 2004. Time-resolved fluorescence measurements using microlens array and area imaging devices. Comb. Chem. High Throughput Screen. 7:45-54
93. Stubbs CD, Botchway SW, Slater SJ, Parker AW. 2005. The use of time-resolved fluorescence imaging in the study of protein kinase C localisation in cells. BMC Cell Biol. 6:22
94. Sevick-Muraca EM, Houston JP, Gurfinkel M. 2002. Fluorescence-enhanced, near infrared diagnostic imaging with contrast agents. Curr. Opin. Chem. Biol. 6:642-50
95. Sevick-Muraca EM, Reynolds JS, Troy TL, Lopez G, Paithankar DY. 1998. Fluorescence lifetime spectroscopic imaging with measurements of photon migration. Ann. NY Acad. Sci. 838:46-57
96. Levenson RM. 2006. Spectral imaging perspective on cytomics. Cytometry 69:592-600
97. Long JZ, Lackan CS, Hadjantonakis AK. 2005. Genetic and spectrally distinct in vivo imaging: embryonic stem cells and mice with widespread expression of a monomeric red fluorescent protein. BMC Biotechnol. 5:20
98. Nighswander-Rempel SP, Kupriyanov VV, Shaw RA. 2005. Relative contributions of hemoglobin and myoglobin to near-infrared spectroscopic images of cardiac tissue. Appl. Spectrosc. 59:190-93
99. Ye Y, Bloch S, Xu B, Achilefu S. 2006. Design, synthesis, and evaluation of near infrared fluorescent multimeric RGD peptides for targeting tumors. J. Med. Chem. 49:2268-75
100. Zacharias DA, Tsien RY. 2006. Molecular biology and mutation of green fluorescent protein. Methods Biochem. Anal. 47:83-120
101. Shaner NC, Steinbach PA, Tsien RY. 2005. A guide to choosing fluorescent proteins. Nat. Methods 2:905-9
102. Giepmans BN, Adams SR, Ellisman MH, Tsien RY. 2006. The fluorescent toolbox for assessing protein location and function. Science 312:217-24
103. Hsu ER, Anslyn EV, Dharmawardhane S, Alizadeh-Naderi R, Aaron JS, et al. 2004. A far-red fluorescent contrast agent to image epidermal growth factor receptor expression. Photochem. Photobiol. 79:272-79
104. Sakatani K, Kashiwasake-Jibu M, Taka Y, Wang S, Zuo H, et al. 1997. Noninvasive optical imaging of the subarachnoid space and cerebrospinal fluid pathways based on near-infrared fluorescence. J. Neurosurg. 87:738-45
105. Reynolds JS, Troy TL, Mayer RH, Thompson AB, Waters DJ, et al. 1999. Imaging of spontaneous canine mammary tumors using fluorescent contrast agents. Photochem. Photobiol. 70:87-94
106. Zheng G, Li H, Yang K, Blessington D, Licha K, et al. 2002. Tricarbocyanine cholesteryl laurates labeled LDL: new near infrared fluorescent probes (NIRFs) for monitoring tumors and gene therapy of familial hypercholesterolemia. Bioorg. Med. Chem. Lett. 12:1485-88
107. Becker A, Hessenius C, Licha K, Ebert B, Sukowski U, et al. 2001. Receptor-targeted optical imaging of tumors with near-infrared fluorescent ligands. Nat. Biotechnol. 19:327-31
108. Becker A, Riefke B, Ebert B, Sukowski U, Rinneberg H, et al. 2000. Macromolecular contrast agents for optical imaging of tumors: comparison of indotricarbocyanine-labeled human serum albumin and transferrin. Photochem. Photobiol. 72:234-41
109. Shah K, Tung CH, Chang CH, Slootweg E, O'Loughlin T, et al. 2004. In vivo imaging of HIV protease activity in amplicon vector-transduced gliomas. Cancer Res. 64:273-78
110. Ponomarev V, Doubrovin M, Serganova I, Vider J, Shavrin A, et al. 2004. A novel triple-modality reporter gene for whole-body fluorescent, bioluminescent, and nuclear noninvasive imaging. Eur. J. Nucl. Med. Mol. Imaging 31:740-51
111. Doubrovin M, Ponomarev V, Serganova I, Soghomonian S, Myagawa T, et al. 2003. Development of a new reporter gene system-dsRed/xanthine phosphoribosyltransferase-xanthine for molecular imaging of processes behind the intact blood-brain barrier. Mol. Imaging 2:93-112
112. Drezek RA, Richards-Kortum R, Brewer MA, Feld MS, Pitris C, et al. 2003. Optical imaging of the cervix. Cancer 98:2015-27
113. Flusberg BA, Cocker ED, Piyawattanametha W, Jung JC, Cheung EL, Schnitzer MJ. 2005. Fiber-optic fluorescence imaging. Nat. Methods 2:941-50
114. Funovics MA, Alencar H, Su HS, Khazaie K, Weissleder R, Mahmood U. 2003. Miniaturized multichannel near infrared endoscope for mouse imaging. Mol. Imaging 2:350-57
115. Sokolov K, Aaron J, Hsu B, Nida D, Gillenwater A, et al. 2003. Optical systems for in vivo molecular imaging of cancer. Technol. Cancer Res. Treat. 2:491-504
116. Sokolov K, Sung KB, Collier T, Clark A, Arifler D, et al. 2002. Endoscopic microscopy. Dis. Markers 18:269-91
117. Wang TD, Contag CH, Mandella MJ, Chan NY, Kino GS. 2003. Dual-axes confocal microscopy with post-objective scanning and low-coherence heterodyne detection. Opt. Lett. 28:1915-17
118. Wang TD, Contag CH, Mandella MJ, Chan NY, Kino GS. 2004. Confocal fluorescence microscope with dual-axis architecture and biaxial postobjective scanning. J. Biomed. Opt. 9:735-42
119. Wang TD, Mandella MJ, Contag CH, Kino GS. 2003. Dual-axis confocal microscope for high-resolution in vivo imaging. Opt. Lett. 28:414-46
120. Tyszka JM, Ewald AJ, Wallingford JB, Fraser SE. 2006. New tools for visualization and analysis of morphogenesis in spherical embryos. Dev. Dyn. 234(4):974-83
121. Liebling M, Forouhar AS, Gharib M, Fraser SE, Dickinson ME. 2005. Four-dimensional cardiac imaging in living embryos via postacquisition synchronization of nongated slice sequences. J. Biomed. Opt. 10:54001-11
122. Jones EA, Baron MH, Fraser SE, Dickinson ME. 2005. Dynamic in vivo imaging of mammalian hematovascular development using whole embryo culture. Methods Mol. Med. 105:381-94
123. Halin C, Rodrigo Mora J, Sumen C, von Andrian UH. 2005. In vivo imaging of lymphocyte trafficking. Annu. Rev. Cell. Dev. Biol. 21:581-603
124. von Andrian UH. 2002. Immunology. T cell activation in six dimensions. Science 296:1815-17
125. Sipkins DA, Wei X, Wu JW, Runnels JM, Cote D, et al. 2005. In vivo imaging of specialized bone marrow endothelial microdomains for tumour engraftment. Nature 435:969-73
126. Dewhirst MW, Shan S, Cao Y, Moeller B, Yuan F, Li CY. 2002. Intravital fluorescence facilitates measurement of multiple physiologic functions and gene expression in tumors of live animals. Dis. Markers 18:293-311
127. Germain RN, Castellino F, Chieppa M, Egen JG, Huang AY, et al. 2005. An extended vision for dynamic high-resolution intravital immune imaging. Semin. Immunol. 17:431-41
128. Mazo IB, Gutierrez-Ramos JC, Frenette PS, Hynes RO, Wagner DD, von Andrian UH. 1998. Hematopoietic progenitor cell rolling in bone marrow microvessels: parallel contributions by endothelial selectins and vascular cell adhesion molecule 1. J. Exp. Med. 188:465-74
129. Sumen C, Mempel TR, Mazo IB, von Andrian UH. 2004. Intravital microscopy: visualizing immunity in context. Immunity 21:315-29
130. von Andrian UH, Arfors KE. 1993. Neutrophil-endothelial cell interactions in vivo: a chain of events characterized by distinct molecular mechanisms. Agents Actions Suppl. 41:153-64
131. Tang Q, Krummel MF. 2006. Imaging the function of regulatory T cells in vivo. Curr. Opin. Immunol. 18:496-502
132. Flusberg BA, Jung JC, Cocker ED, Anderson EP, Schnitzer MJ. 2005. In vivo brain imaging using a portable 3.9 gram two-photon fluorescence microendoscope. Opt. Lett. 30:2272-74
133. MacAulay C, Lane P, Richards-Kortum R. 2004. In vivo pathology: microendoscopy as a new endoscopic imaging modality. Gastrointest Endosc. Clin. N. Am. 14:595-620, xi
134. Yang G, Hellstrom KE, Hellstrom I, Chen L. 1995. Antitumor immunity elicited by tumor cells transfected with B7-2, a second ligand for CD28/CTLA-4 costimulatory molecules. J. Immunol. 154:2794-800
135. Yang M, Chishima T, Wang X, Baranov E, Shimada H, et al. 1999. Multi-organ metastatic capability of Chinese hamster ovary cells revealed by green fluorescent protein (GFP) expression. Clin. Exp. Metastasis. 17:417-22
136. Yang M, Hasegawa S, Jiang P, Wang X, Tan Y, et al. 1998. Widespread skeletal metastatic potential of human lung cancer revealed by green fluorescent protein expression. Cancer Res. 58:4217-21
137. Yang M, Jiang P, An Z, Baranov E, Li L, et al. 1999. Genetically fluorescent melanoma bone and organ metastasis models. Clin. Cancer Res. 5:3549-59
138. Yang M, Jiang P, Sun FX, Hasegawa S, Baranov E, et al. 1999. A fluorescent orthotopic bone metastasis model of human prostate cancer. Cancer Res. 59:781-86
139. Chishima T, Miyagi Y, Li L, Tan Y, Baranov E, et al. 1997. Use of histoculture and green fluorescent protein to visualize tumor cell host interaction. In Vitro Cell Dev. Biol. Anim. 33:745-47
140. Chishima T, Miyagi Y, Wang X, Baranov E, Tan Y, et al. 1997. Metastatic patterns of lung cancer visualized live and in process by green fluorescence protein expression. Clin. Exp. Metastasis. 15:547-52
141. Chishima T, Miyagi Y, Wang X, Tan Y, Shimada H, et al. 1997. Visualization of the metastatic process by green fluorescent protein expression. Anticancer Res. 17:2377-84
142. Chishima T, Miyagi Y, Wang X, Yamaoka H, Shimada H, et al. 1997. Cancer invasion and micrometastasis visualized in live tissue by green fluorescent protein expression. Cancer Res. 57:2042-47
143. Chishima T, Yang M, Miyagi Y, Li L, Tan Y, et al. 1997. Governing step of metastasis visualized in vitro. Proc. Natl. Acad. Sci. USA 94:11573-76
144. Hoffman RM. 1998. Orthotopic transplant mouse models with green fluorescent protein-expressing cancer cells to visualize metastasis and angiogenesis. Cancer Metastasis. Rev. 17:271-77
145. Ropp JD, Donahue CJ, Wolfgang-Kimball D, Hooley JJ, Chin JY, et al. 1995. Aequorea green fluorescent protein analysis by flow cytometry. Cytometry 21:309-17
146. Naumov GN, Wilson SM, MacDonald IC, Schmidt EE, Morris VL, et al. 1999. Cellular expression of green fluorescent protein, coupled with high-resolution in vivo videomicroscopy, to monitor steps in tumor metastasis. J. Cell Sci. 112(Pt. 12):1835-42
147. Matz MV, Fradkov AF, Labas YA, Savitsky AP, Zaraisky AG, et al. 1999. Fluorescent proteins from nonbioluminescent Anthozoa species. Nat. Biotechnol. 17:969-73
148. Miyawaki A. 2002. Green fluorescent protein-like proteins in reef Anthozoa animals. Cell Struct. Funct. 27:343-47
149. Shaner NC, Campbell RE, Steinbach PA, Giepmans BN, Palmer AE, Tsien RY. 2004. Improved monomeric red, orange and yellow fluorescent proteins derived from Discosoma sp. red fluorescent protein. Nat. Biotechnol. 22:1567-72
150. Zaccolo M, De Giorgi F, Cho CY, Feng L, Knapp T, et al. 2000. A genetically encoded, fluorescent indicator for cyclic AMP in living cells. Nat. Cell Biol. 2:25-29
151. Campbell RE, Tour O, Palmer AE, Steinbach PA, Baird GS, et al. 2002. A monomeric red fluorescent protein. Proc. Natl. Acad. Sci. USA 99:7877-82
152. Fradkov AF, Verkhusha VV, Staroverov DB, Bulina ME, Yanushevich YG, et al. 2002. Far-red fluorescent tag for protein labelling. Biochem. J. 368:17-21
153. Gurskaya NG, Savitsky AP, Yanushevich YG, Lukyanov SA, Lukyanov KA. 2001. Color transitions in coral's fluorescent proteins by site-directed mutagenesis. BMC Biochem. 2:6
154. Patterson GH. 2004. A new harvest of fluorescent proteins. Nat. Biotechnol. 22:1524-25
155. Edinger M, Cao YA, Verneris MR, Bachmann MH, Contag CH, Negrin RS. 2003. Revealing lymphoma growth and the efficacy of immune cell therapies using in vivo bioluminescence imaging. Blood 101:640-48
156. Ray P, De A, Min JJ, Tsien RY, Gambhir SS. 2004. Imaging tri-fusion multimodality reporter gene expression in living subjects. Cancer Res. 64:1323-30
157. Day RN, Kawecki M, Berry D. 1998. Dual-function reporter protein for analysis of gene expression in living cells. Biotechniques 25:848-50, 52-54, 56
158. Edinger M, Sweeney TJ, Tucker AA, Olomu AB, Negrin RS, Contag CH. 1999. Non-invasive assessment of tumor cell proliferation in animal models. Neoplasia 1:303-10
159. Costa GL, Sandora MR, Nakajima A, Nguyen EV, Taylor-Edwards C, et al. 2001. Adoptive immunotherapy of experimental autoimmune encephalomyelitis via T cell delivery of the IL-12 p40 subunit. J. Immunol. 167:2379-87
160. Hardy J, Edinger M, Bachmann MH, Negrin RS, Fathman CG, Contag CH. 2001. Bioluminescence imaging of lymphocyte trafficking in vivo. Exper. Hematol. 29: 353-60
161. Mandl S, Schimmelpfennig C, Edinger M, Negrin RS, Contag CH. 2002. Understanding immune cell trafficking patterns via in vivo bioluminescence imaging. J. Cell Biochem. Suppl. 39:239-48
162. Mandl SJ, Mari C, Edinger M, Negrin RS, Tait JF, et al. 2004. Multi-modality imaging identifies key times for annexin V imaging as an early predictor of therapeutic outcome. Mol. Imaging 3:1-8
163. Edinger M, Hoffmann P, Contag CH, Negrin RS. 2003. Evaluation of effector cell fate and function by in vivo bioluminescence imaging. Methods 31:172-79
164. Mandl S, Mari C, Edinger M, Negrin RS, Tait JF, et al. 2003. Multi-modality imaging identifies key times for annexin V imaging as an early predictor of therapeutic outcome. Mol. Imaging 3:1-8
165. Shizuru JA, Negrin RS, Weissman IL. 2005. Hematopoietic stem and progenitor cells: clinical and preclinical regeneration of the hematolymphoid system. Annu. Rev. Med. 56:509-38
166. Wagers AJ, Sherwood RI, Christensen JL, Weissman IL. 2002. Little evidence for developmental plasticity of adult hematopoietic stem cells. Science 297:2256-59
167. Cao YA, Wagers AJ, Beilhack A, Dusich J, Bachmann MH, et al. 2004. Shifting foci of hematopoiesis during reconstitution from single stem cells. Proc. Natl. Acad. Sci. USA 101:221-26
168. Donnelly ML, Hughes LE, Luke G, Mendoza H, ten Dam E, et al. 2001. The 'cleavage' activities of foot-and-mouth disease virus 2A site-directed mutants and naturally occurring '2A-like' sequences. J. Gen. Virol. 82:1027-41
169. Donnelly ML, Luke G, Mehrotra A, Li X, Hughes LE, et al. 2001. Analysis of the aphthovirus 2A/2B polyprotein 'cleavage' mechanism indicates not a proteolytic reaction, but a novel translational effect: a putative ribosomal 'skip.' J. Gen. Virol. 82:1013-25
170. Wang X, Rosol M, Ge S, Peterson D, McNamara G, et al. 2003. Dynamic tracking of human hematopoietic stem cell engraftment using in vivo bioluminescence imaging. Blood 102:3478-82
171. Cao YA, Bachmann MH, Beilhack A, Yang Y, Tanaka M, et al. 2005. Molecular imaging using labeled donor tissues reveals patterns of engraftment, rejection, and survival in transplantation. Transplantation 80:134-39
172. Shachaf CM, Kopelman AM, Arvanitis C, Karlsson A, Beer S, et al. 2004. MYC inactivation uncovers pluripotent differentiation and tumour dormancy in hepatocellular cancer. Nature 431:1112-17
173. Morrison SJ, Qian D, Jerabek L, Thiel BA, Park IK, et al. 2002. A genetic determinant that specifically regulates the frequency of hematopoietic stem cells. J. Immunol. 168:635-42